Shahid Beheshti University of Medical Sciences is one of the three medical universities in Tehran, the capital of Iran. It began in 1961 with the establishment of the Schools of Medicine and Dentistry.

During the past decade, SBMU conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SBMU" #1 collaborator was "Tarbiat Modarres University" with 1 trials as a collaborator and "praxisgemeinschaft für zelltherapie" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "SBMU" are "COVID-19" (2 trials), "Antibody-mediated Rejection" (1 trials), "Cerebrovascular Disorders" (1 trials), "Corona Virus Infection" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "SBMU" in a lesser frequency.

Most popular intervention types in "SBMU" are "Drug" (5 trials), "Diagnostic Test" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bortezomib" (1 trials), "Colchicine Tablets" (1 trials), "Cycle threshold" (1 trials) and "Dietary Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "SBMU" are 11 trials for "All" genders.

Currently, there are NaN active trials in "SBMU". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in SBMU, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SBMU, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".